May act as a tumor suppressor. Abundantly expressed in placenta. Less abundant expression in mammary gland and ovary. Expression is barely detectable levels in all other tissues tested. Down-regulated in breast tumors. Belongs to the ITIH family. Conflict in position 933 in the human genome assembly due to a frameshift.